Back

Fine particulate matter exposure and the risk of peripheral revascularization: a post-hoc AIRCARD analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk of peripheral artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Stephan Peronard Mayntz

Odense University Hospital, Odense (Denmark)

6 More presentations in this session

Presentation thumbnail
Impact of the below-knee lower extremity arterial calcification score on clinical outcomes in patients with intermittent claudication due to iliofemoral artery disease
Doctor K. Kawamura (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Longitudinal change in ankle-brachial index and incident cardiovascular disease and all-cause mortality
Doctor J. Song (Qingdao, CN)
Abstract Slides Video
Presentation thumbnail
Categorization of patients with peripheral artery disease by charlson comorbidity index
Doctor M. Meertens (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Differences between female and male sarcopenic patients with peripheral artery disease
Doctor V. Schmitt (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Peripheral artery disease risk prediction in patients with severe aortic valve stenosis
Doctor M. Steinmetz (Bochum, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk of peripheral artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Association of PM2.5 long-term exposure with coronary artery disease severity and calcification assessed by coronary CT-angiography
thumbnail
Congress Presentation
Age and sex differences in the effects of short- and long-term exposure to air pollution on endothelial dysfunction
thumbnail
Congress Presentation
Interactive effects of outdoor fine particulate matter and metabolic, behavioural, and psychosocial risk factors on cardiovascular disease: analysis of the PURE-China cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources